{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:42:47Z","timestamp":1791308567280,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.4158\/ep-2017-0027","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:23:43Z","timestamp":1510845823000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Dpp4 Inhibitor Sitagliptin As A Potential Treatment Option In Metformin-Intolerant Obese Women With Polycystic Ovary Syndrome: A Pilot Randomized Study"],"prefix":"10.1016","volume":"24","author":[{"given":"Simona","family":"Ferjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Janez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Jensterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2017-0027_bb0010","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0027_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2010.03934.x","article-title":"When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?","volume":"74","author":"Franks","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2017-0027_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2017-0027_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1472-6483(10)60809-7","article-title":"Metformin monotherapy in lean women with polycystic ovary syndrome","volume":"10","author":"Kumari","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.4158\/EP-2017-0027_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09513590701192529","article-title":"Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity","volume":"23","author":"Marcondes","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.4158\/EP-2017-0027_bb0035","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/db14-1388","article-title":"Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study","volume":"64","author":"Dujic","year":"2015","journal-title":"Diabetes"},{"key":"10.4158\/EP-2017-0027_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3810\/pgm.2010.03.2128","article-title":"Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes","volume":"122","author":"Florez","year":"2010","journal-title":"Postgrad Med"},{"key":"10.4158\/EP-2017-0027_bb0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.4158\/EP-2017-0027_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2017-0027_bb0055","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0027_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2016.08.026","article-title":"Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome","volume":"207","author":"Orio","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.4158\/EP-2017-0027_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"All women with PCOS should be treated for insulin resistance","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil Steril"},{"key":"10.4158\/EP-2017-0027_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","article-title":"Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved \u03b2-cell function and insulin sensitivity in metformin treated PCOS","volume":"42","author":"Jensterle","year":"2017","journal-title":"Endocr Res"},{"key":"10.4158\/EP-2017-0027_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2009.03764.x","article-title":"The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose","volume":"73","author":"Bock","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2017-0027_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diabres.2010.06.012","article-title":"Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose","volume":"90","author":"Perreault","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP-2017-0027_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/dc07-1616","article-title":"Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance","volume":"31","author":"Rosenstock","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0027_bb0090","series-title":"Polycystic Ovary Syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome","author":"Zawadzki","year":"1992"},{"issue":"suppl 1","key":"10.4158\/EP-2017-0027_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/dc17-S005","article-title":"Standards of medical care in diabetes-2017: classification and diagnosis of diabetes","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0027_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12902-015-0018-1","article-title":"Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride","volume":"15","author":"Zheng","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.4158\/EP-2017-0027_bb0105","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0027_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.4158\/EP-2017-0027_bb0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj.EJ12-0416","article-title":"Association between beta cell function and future glycemic control in patients with type 2 diabetes","volume":"60","author":"Saisho","year":"2013","journal-title":"Endocr J"},{"key":"10.4158\/EP-2017-0027_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2017-0027_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/dc11-1272","article-title":"Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study","volume":"35","author":"de Mello","year":"2012","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0027_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-8847","article-title":"Exercise and insulin sensitivity: a review","volume":"21","author":"Borghouts","year":"2000","journal-title":"Int J Sports Med"},{"key":"10.4158\/EP-2017-0027_bb0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2013-2687","article-title":"Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults","volume":"99","author":"Rynders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0027_bb0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/dmrr.505","article-title":"Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance","volume":"20","author":"Hawley","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.4158\/EP-2017-0027_bb0145","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2006-2794","article-title":"Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome","volume":"92","author":"Vigorito","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0027_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1463-1326.2011.01473.x","article-title":"Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence","volume":"14","author":"van Genugten","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2017-0027_bb0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"Svendsen","year":"2009","journal-title":"Metabolism"},{"key":"10.4158\/EP-2017-0027_bb0160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2147\/VHRM.S1707","article-title":"Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes","volume":"4","author":"Richter","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.4158\/EP-2017-0027_bb0165","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3892\/etm.2016.3081","article-title":"Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: randomized control study","volume":"11","author":"Jensterle","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.4158\/EP-2017-0027_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"key":"10.4158\/EP-2017-0027_bb0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2337\/diacare.24.3.489","article-title":"Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects","volume":"24","author":"Mannucci","year":"2001","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0027_bb0180","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-291X(02)02565-2","article-title":"Enhanced secretion of glucagon-like peptide 1 by biguanide compounds","volume":"298","author":"Yasuda","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP-2017-0027_bb0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2014.00140","article-title":"The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study","volume":"5","author":"Rasmussen","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.4158\/EP-2017-0027_bb0190","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2337\/db13-1455","article-title":"Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade","volume":"63","author":"Aulinger","year":"2014","journal-title":"Diabetes"},{"key":"10.4158\/EP-2017-0027_bb0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/VHRM.S10952","article-title":"Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience","volume":"6","author":"Foley","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.4158\/EP-2017-0027_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2042018810380215","article-title":"Role of metformin in the management of polycystic ovary syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:19Z","timestamp":1761516319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20393435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1530891X20393435"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0027","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dpp4 Inhibitor Sitagliptin As A Potential Treatment Option In Metformin-Intolerant Obese Women With Polycystic Ovary Syndrome: A Pilot Randomized Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}